Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Susan Young Rojahn

A View from Susan Young Rojahn

Are Surgical Robots Worth It?

The FDA looks into the safety of the da Vinci system in light of increased adverse incidents.

  • March 1, 2013

Surgical robots allow surgeons to perform a variety of less invasive operations because their miniaturized instruments can work through small incisions in the body and are more dexterous than traditional laparoscopic tools (see “The Slow Rise of the Robot Surgeon”).  The result is that patients leave the operating room with a smaller surgical wound with the promise of faster recovery and less scarring.  

Da Vinci Surgical Robot

In 2000, Intuitive Surgical’s da Vinci system became the first FDA-approved commercially available robotic surgical platform and has since been used on hundreds of thousands of patients. According to a report on Bloomberg’s news site, the FDA is now taking another look at the system in response to an increase in reports of adverse incidents. As reported by Bloomberg:

What the agency is trying to determine is whether a rise seen in incident reports sent to the agency are “a true reflection of problems” with the robots, or the result of other issues, said Synim Rivers, an [FDA] spokeswoman, in an e-mail. “It is difficult to know why the reports have increased,” she said.

The increase in incidents could be due to the growing number of surgeries performed by the robotic systems, which are not automated but instead driven by a surgeon in a seated at a console. Still, the rise in reports has tripped the wires of the FDA’s Adverse Event Reporting System, so the agency is surveying surgeons on complications they’ve seen and their training, according to Bloomberg.

The systems are quite costly (around $2.5 million) and recent studies suggest they may not provide the improved patient safety that they promise. Researchers reported in the Journal of the American Medical Association last week that robotic-assisted hysterectomies had similar rates of complications to laparoscopic surgeries (which also involves small incisions). The researchers did identify a major difference—the cost of the surgeries. The robotic surgeries cost on average $2,139 more than the laparoscopic procedures.

Image: Intuitive Surgical

The latest Insider Conversation is live! Listen to the story behind the story.

Subscribe today
Already a Premium subscriber? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.